PROSPECTIVE EVOLUTION OF THE EFFICACY OF ANTIARRHYTHMIC THERAPY IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN PATIENTS WITH PREEXCITATION SYNDROME

被引：0
|
作者：
FOMINA, IG
YANKIN, VV
机构：
来源：
KLINICHESKAYA MEDITSINA | 1992年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Evolution of the effectiveness of antiarrhythmic drugs used in 240 patients with preexcitation syndrome to arrest episodes of paroxysmal supraventricular tachycardia was analysed prospectively. The first intravenous administration was effective in 97, 93.3, 80.9, 75, 70.3, 60, 48 % of cases for novocainamid, verapamil, cordarone, disopyramide. ajmaline, ethacizine, mexitil and inderal, respectively. When observed in prospective evolution for 10-14 years, overall group efficacy dropped from 81.3% at first administration to 21.4%.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 50 条
  • [31] EFFICACY OF PIRMENOL, A NEW ANTIARRHYTHMIC AGENT, IN TERMINATING SUPRAVENTRICULAR TACHYCARDIA
    BARNARD, D
    HAFFAJEE, C
    GOLD, R
    SLOAN, K
    ALPERT, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A247 - A247
  • [32] CIBENZOLINE - ELECTROPHYSIOLOGIC EFFECTS OF A NEW CLASS-1-ANTIARRHYTHMIC AGENT IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
    PFITZNER, P
    MANZ, M
    SCHUTZ, R
    LUDERITZ, B
    ZEITSCHRIFT FUR KARDIOLOGIE, 1989, 78 (10): : 654 - 660
  • [33] PROSPECTIVE EVOLUTION OF THE THERAPY ARRESTING THE ATTACKS OF ATRIAL-FIBRILLATION IN PATIENTS WITH PREEXCITATION SYNDROME
    FOMINA, IG
    YANKIN, VV
    KLINICHESKAYA MEDITSINA, 1992, 70 (02): : 37 - 40
  • [34] PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA INDUCTION IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME
    DENES, P
    WU, D
    AMATYLEON, F
    DHINGRA, R
    WYNDHAM, C
    KEHOE, R
    AYRES, BF
    ROSEN, KM
    ANNALS OF INTERNAL MEDICINE, 1979, 90 (02) : 153 - 157
  • [35] Prevention Of Inappropriate ICD Therapy Due To Supraventricular Tachycardia In Patients With Brugada Syndrome - A Prospective Study
    Veltmann, Christian
    Schimpf, Rainer
    Kuschyk, Juergen
    Streitner, Florian
    Borggrefe, Martin
    Wolpert, Christian
    CIRCULATION, 2008, 118 (18) : S594 - S594
  • [36] EFFICACY AND SAFETY OF INTRAVENOUS SOTALOL FOR TERMINATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
    JORDAENS, L
    GORGELS, A
    STROOBANDT, R
    TEMMERMAN, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (01): : 35 - 40
  • [37] Artesunate enhances the efficacy of amiodarone for cardioversion of paroxysmal supraventricular tachycardia
    Zeng Aihong
    Ou Yang-Ying
    Guo Ming-Ming
    Dai-Xuan
    Zhou De-Zhi
    Zan Hong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C200 - C200
  • [38] Supraventricular tachycardia in infancy and childhood: diagnosis, antiarrhythmic and interventional therapy
    Paul, T
    Bertram, H
    Kriebel, T
    Windhagen-Mahnert, B
    Tebbenjohanns, J
    Hausdorf, C
    ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 (06): : 546 - 558
  • [39] Efficacy and Mechanism of Intravenous Sotalol for Termination of Paroxysmal Supraventricular Tachycardia
    陈椿
    黄元铸
    陆凤翔
    曹克将
    马文珠
    JournalofNanjingMedicalUniversity, 2000, (02) : 96 - 100
  • [40] Prevalence of stroke among patients with paroxysmal supraventricular tachycardia
    Brembilla-Perrot, B.
    Delobelle, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 233 - 233
12345